I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…
In phase 3 trials, the drug raised hemoglobin better than epoetin alfa, with improved CV safety.
In a phase 3 trial, difelikefalin, a kappa opioid receptor agonist, significant decreased itching and improved itching-related quality of life among dialysis patients suffering from pruritus.
In a real-world study, 3% of AKI events potentially related to use of immune checkpoint inhibitor therapy — a higher rate than reported in clinical trials.
Physicians must be open about secondary interests such as financial gain that have the potential to bias their clinical judgment.
In hiring patient engagers, providers should be look for such customer service qualities as positivity, patience, and good problem-solving and communication skills.
Men with biochemically recurrent nonmetastatic prostate cancer following radical prostatectomy have long survival times from the time of surgery without hormonal treatment, a study found.
Study findings suggest that many men can be spared radiation therapy following radical prostatectomy for high-risk prostate cancer.
